{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:30:47Z","timestamp":1792679447643,"version":"4.5.0"},"reference-count":193,"publisher":"American Diabetes Association","issue":"Supplement_1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:p>The American Diabetes Association (ADA) \u201cStandards of Care in Diabetes\u201d includes the ADA\u2019s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee for Diabetes, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA\u2019s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org\/SOC.<\/jats:p>","DOI":"10.2337\/dc26-s007","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T14:52:19Z","timestamp":1765205539000},"page":"S150-S165","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":168,"title":["7. Diabetes Technology: Standards of Care in Diabetes\u20142026"],"prefix":"10.2337","volume":"49","author":[{"name":"American Diabetes Association Professional Practice Committee for Diabetes*","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7263-5425","authenticated-orcid":false,"given":"Mandeep","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-3183","authenticated-orcid":false,"given":"Rozalina G.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-6037","authenticated-orcid":false,"given":"Kirthikaa","family":"Balapattabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-5783","authenticated-orcid":false,"given":"Raveendhara R.","family":"Bannuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4439-7374","authenticated-orcid":false,"given":"Natalie J.","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-8329","authenticated-orcid":false,"given":"Allison K.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6486-8234","authenticated-orcid":false,"given":"Elizabeth A.","family":"Beverly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-2548","authenticated-orcid":false,"given":"Kathaleen","family":"Briggs Early","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8487-5485","authenticated-orcid":false,"given":"Sathyavathi","family":"ChallaSivaKanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8460-1617","authenticated-orcid":false,"given":"Justin B.","family":"Echouffo-Tcheugui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6331-5224","authenticated-orcid":false,"given":"Brendan M.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-1619","authenticated-orcid":false,"given":"Rajesh","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-3001","authenticated-orcid":false,"given":"Lori M.","family":"Laffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8055-944X","authenticated-orcid":false,"given":"Rayhan","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Matfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-9504","authenticated-orcid":false,"given":"Naushira","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6258-3975","authenticated-orcid":false,"given":"Elizabeth J.","family":"Pekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-0776","authenticated-orcid":false,"given":"Anne L.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-9047","authenticated-orcid":false,"given":"Scott J.","family":"Pilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0572-7538","authenticated-orcid":false,"given":"Giulio R.","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9903-4002","authenticated-orcid":false,"given":"Sylvia E.","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-9598","authenticated-orcid":false,"given":"Alissa R.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7399-3934","authenticated-orcid":false,"given":"Emily D.","family":"Szmuilowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-4916","authenticated-orcid":false,"given":"Nuha A.","family":"ElSayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"2026091111520584100_B1","doi-asserted-by":"crossref","first-page":"e3037","DOI":"10.1210\/clinem\/dgab188","article-title":"Diabetes knowledge and metabolic control in type 1 diabetes starting with continuous glucose monitoring: FUTURE-PEAK","volume":"106","author":"Broos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091111520584100_B2","doi-asserted-by":"crossref","first-page":"109209","DOI":"10.1016\/j.diabres.2022.109209","article-title":"Effect of structured individualized education on continuous glucose monitoring use in poorly controlled patients with type 1 diabetes: a randomized controlled trial","volume":"184","author":"Yoo","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091111520584100_B3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2337\/dc21-2004","article-title":"Continuous glucose monitoring initiation within first year of type 1 diabetes diagnosis is associated with improved glycemic outcomes: 7-year follow-up study","volume":"45","author":"Champakanath","year":"2022","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/dia.2019.0026","article-title":"Early initiation of diabetes devices relates to improved glycemic control in children with recent-onset type 1 diabetes mellitus","volume":"21","author":"Patton","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/clinem\/dgab859","article-title":"Teamwork, targets, technology, and tight control in newly diagnosed type 1 diabetes: the Pilot 4T Study","volume":"107","author":"Prahalad","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091111520584100_B6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/pedi.13082","article-title":"Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance","volume":"21","author":"Addala","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"2026091111520584100_B7","doi-asserted-by":"crossref","first-page":"e14567","DOI":"10.1111\/dme.14567","article-title":"\u201cI was ready for it at the beginning\u201d: parent experiences with early introduction of continuous glucose monitoring following their child\u2019s type 1 diabetes diagnosis","volume":"38","author":"Tanenbaum","year":"2021","journal-title":"Diabet Med"},{"key":"2026091111520584100_B8","article-title":"Sustained HbA1c improvements over 36 months in youth in the Teamwork, Targets, Technology, and Tight Control (4T) study","author":"Prahalad","journal-title":"J Clin Endo Met."},{"key":"2026091111520584100_B9","doi-asserted-by":"crossref","first-page":"1970247","DOI":"10.1155\/jdr\/1970247","article-title":"Peer mentoring improves diabetes technology use and reduces diabetes distress among underserved communities: outcomes of a pilot diabetes support coach intervention","volume":"2025","author":"Maizel","year":"2025","journal-title":"J Diabetes Res"},{"key":"2026091111520584100_B10","article-title":"Older adults benefit from virtual support for continuous glucose monitor use but require longer visits","author":"Weinstock","year":"2024","journal-title":"J Diabetes Sci Technol."},{"key":"2026091111520584100_B11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/dia.2024.0096","article-title":"The type of patient training does not impact outcomes in the first 90 days of automated insulin delivery use","volume":"26","author":"Meighan","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/26350106221120889","article-title":"Professional competencies for diabetes technology use in the care setting","volume":"48","author":"Patil","year":"2022","journal-title":"Sci Diabetes Self Manag Care"},{"key":"2026091111520584100_B13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"key":"2026091111520584100_B14","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.2337\/dc14-S112","article-title":"Diabetes and employment","volume":"37","author":"Anderson","year":"2014","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/KTFR5698","article-title":"The effect of closed-loop glucose control on C-peptide secretion in youth with newly diagnosed type 1 diabetes: the CLOuD RCT","author":"Boughton","year":"2024","journal-title":"Efficacy Mech Eval"},{"key":"2026091111520584100_B16","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1097\/pq9.0000000000000803","article-title":"Initiating insulin pumps in youth with new-onset type 1 diabetes: a quality improvement initiative","volume":"10","author":"Vakharia","year":"2025","journal-title":"Pediatr Qual Saf"},{"key":"2026091111520584100_B17","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2337\/dc21-1304","article-title":"The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin","volume":"44","author":"Aleppo","year":"2021","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B18","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1111\/dom.70008","article-title":"Continuous glucose monitoring in noninsulin-treated type 2 diabetes: a critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials","volume":"27","author":"Aronson","journal-title":"Diabetes Obes Metab 2025;"},{"key":"2026091111520584100_B19","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2337\/dc23-0495","article-title":"Association between diabetes technology use and glycemic outcomes in adults with type 1 diabetes over a decade","volume":"46","author":"Karakus","year":"2023","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4158\/EP-2017-0234","article-title":"Improved HbA1c, total daily insulin dose, and treatment satisfaction with insulin pump therapy compared to multiple daily insulin injections in patients with type 2 diabetes irrespective of baseline C-peptide levels","volume":"24","author":"Vigersky","year":"2018","journal-title":"Endocr Pract"},{"key":"2026091111520584100_B21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4158\/EP-2017-0220","article-title":"C-peptide and beta-cell autoantibody testing prior to initiating continuous subcutaneous insulin infusion pump therapy did not improve utilization or medical costs among older adults with diabetes mellitus","volume":"24","author":"Gill","year":"2018","journal-title":"Endocr Pract"},{"key":"2026091111520584100_B22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/dia.2021.0196","article-title":"Lost in translation: a disconnect between the science and medicare coverage criteria for continuous subcutaneous insulin infusion","volume":"23","author":"Aleppo","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1932296819838292","article-title":"Impact of Medicare continuous subcutaneous insulin infusion policies in patients with type 1 diabetes","volume":"14","author":"Argento","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/26350106251337486","article-title":"AGP reports for glucose and insulin devices qualitative study: what patients and clinicians want","volume":"51","author":"Mullen","year":"2025","journal-title":"Sci Diabetes Self Manag Care"},{"key":"2026091111520584100_B25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1089\/dia.2024.0107","article-title":"Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens","volume":"26","author":"Simonson","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B26","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1089\/dia.2019.0034","article-title":"Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice","volume":"21","author":"Johnson","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/dia.2024.0410","article-title":"Comparison of computational statistical packages for the analysis of continuous glucose monitoring data with a reference software, \u201cAmbulatory Glucose Profile,\u201d in type 1 diabetes","volume":"27","author":"Karakus","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up","volume":"39","author":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group","year":"2016","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B29","doi-asserted-by":"crossref","first-page":"e001067","DOI":"10.1136\/bmjdrc-2019-001067","article-title":"System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015","volume":"8","author":"Pleus","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026091111520584100_B30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1932296819856665","article-title":"Clinical evaluation of a new, lower pain, one touch lancing device for people with diabetes: virtually pain-free testing and improved comfort compared to current lancing systems","volume":"15","author":"Grady","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B31","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/1932296816666536","article-title":"Usability of medical devices for patients with diabetes who are visually impaired or blind","volume":"10","author":"Heinemann","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/17434440.2020.1704253","article-title":"Accuracy of a blood glucose monitoring system that recognizes insufficient sample blood volume and allows application of more blood to the same test strip","volume":"17","author":"Harrison","year":"2020","journal-title":"Expert Rev Med Devices"},{"key":"2026091111520584100_B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(01)00742-2","article-title":"Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry","volume":"111","author":"Karter","year":"2001","journal-title":"Am J Med"},{"key":"2026091111520584100_B34","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2337\/dc12-1770","article-title":"Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants","volume":"36","author":"Miller","year":"2013","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B35","first-page":"e119","article-title":"Patients who self-monitor blood glucose and their unused testing results","volume":"21","author":"Grant","year":"2015","journal-title":"Am J Manag Care"},{"key":"2026091111520584100_B36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1932296819867396","article-title":"Patient satisfaction with a new, high accuracy blood glucose meter that provides personalized guidance, insight, and encouragement","volume":"14","author":"Katz","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/jamia\/ocaa007","article-title":"Self-monitoring diabetes with multiple mobile health devices","volume":"27","author":"Shaw","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"2026091111520584100_B38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/jamainternmed.2014.5405","article-title":"Dual use of Department of Veterans Affairs and Medicare benefits and use of test strips in veterans with type 2 diabetes mellitus","volume":"175","author":"Gellad","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026091111520584100_B39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-5448.2010.00650.x","article-title":"Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes","volume":"12","author":"Ziegler","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"2026091111520584100_B40","doi-asserted-by":"crossref","first-page":"e003930","DOI":"10.1136\/bmjdrc-2023-003930","article-title":"Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review","volume":"12","author":"Rosenstock","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026091111520584100_B41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11606-022-07864-z","article-title":"The efficacy and frequency of self-monitoring of blood glucose in non-insulin-treated T2D patients: a systematic review and meta-analysis","volume":"38","author":"Zou","year":"2023","journal-title":"J Gen Intern Med"},{"key":"2026091111520584100_B42","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/jamainternmed.2017.1233","article-title":"Glucose self-monitoring in non-insulin-treated patients with type 2 diabetes in primary care settings: a randomized trial","volume":"177","author":"Young","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2026091111520584100_B43","doi-asserted-by":"crossref","first-page":"1177030","DOI":"10.3389\/fcdhc.2023.1177030","article-title":"The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis","volume":"4","author":"Holmes-Truscott","year":"2023","journal-title":"Front Clin Diabetes Healthc"},{"key":"2026091111520584100_B44","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/1932296818821664","article-title":"Evaluation of linearity and interference effect on SMBG and POCT devices, showing drastic high values, low values, or error messages","volume":"13","author":"Sai","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B45","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.2337\/dci23-0036","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"46","author":"Sacks","year":"2023","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B46","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","article-title":"Continuous glucose monitoring and intensive treatment of type 1 diabetes","volume":"359","author":"Tamborlane","year":"2008","journal-title":"N Engl J Med"},{"key":"2026091111520584100_B47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/dmrr.2557","article-title":"Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial","volume":"31","author":"Tumminia","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"2026091111520584100_B48","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1177\/19322968211019382","article-title":"The frequency of intermittently scanned glucose and diurnal variation of glycemic metrics","volume":"16","author":"Hansen","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jdi.13618","article-title":"Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type\u20091 diabetes","volume":"13","author":"Urakami","year":"2022","journal-title":"J Diabetes Investig"},{"key":"2026091111520584100_B50","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2020.6940","article-title":"Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Laffel","year":"2020","journal-title":"JAMA"},{"key":"2026091111520584100_B51","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc20-1060","article-title":"A randomized clinical trial assessing continuous glucose monitoring (CGM) use with standardized education with or without a family behavioral intervention compared with fingerstick blood glucose monitoring in very young children with type 1 diabetes","volume":"44","author":"Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group","year":"2021","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B52","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/dme.12713","article-title":"Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS)","volume":"32","author":"New","year":"2015","journal-title":"Diabet Med"},{"key":"2026091111520584100_B53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2337\/dc21-0629","article-title":"Continuous glucose monitoring in adults with type 1 diabetes with 35 years duration from the DCCT\/EDIC study","volume":"45","author":"Gubitosi-Klug","year":"2022","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B54","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/dia.2013.0072","article-title":"Continuous glucose monitoring pilot in low-income type 1 diabetes patients","volume":"15","author":"Sequeira","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B55","doi-asserted-by":"crossref","first-page":"e230085","DOI":"10.1530\/EC-23-0085","article-title":"Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes","volume":"12","author":"Friedman","year":"2023","journal-title":"Endocr Connect"},{"key":"2026091111520584100_B56","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00125-021-05648-4","article-title":"Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis","volume":"65","author":"Teo","year":"2022","journal-title":"Diabetologia"},{"key":"2026091111520584100_B57","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2020.6928","article-title":"Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Pratley","year":"2020","journal-title":"JAMA"},{"key":"2026091111520584100_B58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/dia.2021.0503","article-title":"Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes","volume":"24","author":"Miller","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/dia.2021.0494","article-title":"Effectiveness of continuous glucose monitoring in older adults with type 2 diabetes treated with basal insulin","volume":"24","author":"Bao","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B60","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/19322968221084667","article-title":"Long-term continuous glucose monitor use in very young children with type 1 diabetes: one-year results from the SENCE study","volume":"17","author":"Van Name","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B61","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"key":"2026091111520584100_B62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/dia.2021.0212","article-title":"Use of real-time continuous glucose monitoring improves glycemic control and other clinical outcomes in type 2 diabetes patients treated with less intensive therapy","volume":"24","author":"Grace","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B63","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/193229681100500320","article-title":"The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus","volume":"5","author":"Ehrhardt","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B64","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s13300-021-01086-y","article-title":"Episodic real-time CGM use in adults with type 2 diabetes: results of a pilot randomized controlled trial","volume":"12","author":"Price","year":"2021","journal-title":"Diabetes Ther"},{"key":"2026091111520584100_B65","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","article-title":"Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"67","author":"Jancev","year":"2024","journal-title":"Diabetologia"},{"key":"2026091111520584100_B66","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/dia.2023.0390","article-title":"Continuous glucose monitoring systems in noninsulin-treated people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Ferreira","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/dom.14852","article-title":"Efficacy of intermittent short-term use of a real-time continuous glucose monitoring system in non-insulin-treated patients with type 2 diabetes: a randomized controlled trial","volume":"25","author":"Moon","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"2026091111520584100_B68","doi-asserted-by":"crossref","first-page":"1182260","DOI":"10.3389\/fendo.2023.1182260","article-title":"Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications","volume":"14","author":"Manfredo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026091111520584100_B69","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/19322968221139873","article-title":"Real-time continuous glucose monitoring in adolescents and young adults with type 2 diabetes can improve quality of life","volume":"18","author":"Chesser","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B70","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2337\/dc20-0738","article-title":"Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists (ABCD) nationwide audit","volume":"43","author":"Deshmukh","year":"2020","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B71","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/pedi.13128","article-title":"Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well-controlled youth with type 1 diabetes","volume":"21","author":"Charleer","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"2026091111520584100_B72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13098-021-00654-3","article-title":"A review of flash glucose monitoring in type 2 diabetes","volume":"13","author":"Krakauer","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"2026091111520584100_B73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/dia.2021.0034","article-title":"Intermittently scanned continuous glucose monitoring data of polish patients from real-life conditions: more scanning and better glycemic control compared to worldwide data","volume":"23","author":"Hohendorff","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B74","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00125-021-05437-z","article-title":"Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls","volume":"64","author":"Nathanson","year":"2021","journal-title":"Diabetologia"},{"key":"2026091111520584100_B75","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.2337\/dc20-1690","article-title":"Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF study","volume":"44","author":"Roussel","year":"2021","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B76","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/dia.2022.0085","article-title":"Reduced rate of acute diabetes events with flash glucose monitoring is sustained for 2 years after initiation: extended outcomes from the RELIEF study","volume":"24","author":"Riveline","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B77","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.37765\/ajmc.2021.88780","article-title":"Flash CGM associated with event reduction in nonintensive diabetes therapy","volume":"27","author":"Miller","year":"2021","journal-title":"Am J Manag Care"},{"key":"2026091111520584100_B78","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/jama.2021.6530","article-title":"Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes","volume":"325","author":"Karter","year":"2021","journal-title":"JAMA"},{"key":"2026091111520584100_B79","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/dia.2024.0197","article-title":"Long-term improvements in glycemic control with Dexcom CGM use in adults with noninsulin-treated type 2 diabetes","volume":"26","author":"Layne","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B80","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2337\/cd23-0080","article-title":"Recent advances in diabetes technology and activities of the American Diabetes Association Diabetes Technology Interest Group","volume":"42","author":"Akturk","year":"2024","journal-title":"Clin Diabetes"},{"key":"2026091111520584100_B81","unstructured":"Dexcom, Inc\n          . Dexcom G7 Continuous Glucose Monitoring System. Integrated Continuous Glucose Monitoring System, Factory Calibrated. Dexcom, Inc. Accessed 14 August 2025. Available from https:\/\/fda.report\/PMN\/K213919"},{"key":"2026091111520584100_B82","doi-asserted-by":"crossref","first-page":"14791641241253967","DOI":"10.1177\/14791641241253967","article-title":"Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: a real-world prospective observational study","volume":"21","author":"Abitbol","year":"2024","journal-title":"Diab Vasc Dis Res"},{"key":"2026091111520584100_B83","doi-asserted-by":"crossref","first-page":"111950","DOI":"10.1016\/j.diabres.2024.111950","article-title":"Efficacy of flash glucose monitoring on HbA1c in type 2 diabetes: an individual patient data meta-analysis of real-world evidence","volume":"219","author":"Heer","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091111520584100_B84","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.numecd.2020.12.024","article-title":"Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy","volume":"31","author":"Ribeiro","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026091111520584100_B85","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1932296820905577","article-title":"Intermittent use of continuous glucose monitoring: expanding the clinical value of CGM","volume":"15","author":"Ziegler","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B86","doi-asserted-by":"crossref","first-page":"e001115","DOI":"10.1136\/bmjdrc-2019-001115","article-title":"Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial","volume":"8","author":"Wada","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026091111520584100_B87","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2337\/cd22-0080","article-title":"Association between change in A1C and use of professional continuous glucose monitoring in adults with type 2 diabetes on noninsulin therapies: a real-world evidence study","volume":"41","author":"Nemlekar","year":"2023","journal-title":"Clin Diabetes"},{"key":"2026091111520584100_B88","first-page":"600","article-title":"Effect of pharmacist-driven professional continuous glucose monitoring in adults with uncontrolled diabetes","volume":"26","author":"Sherrill","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"2026091111520584100_B89","first-page":"100254","article-title":"Professional continuous glucose monitoring and endocrinology eConsult for adults with type 2 diabetes in primary care: results of a clinical pilot program","volume":"24","author":"Fantasia","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"2026091111520584100_B90","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1932296821998724","article-title":"Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care","volume":"15","author":"Simonson","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B91","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1089\/dia.2019.0171","article-title":"Documentation of skin-related issues associated with continuous glucose monitoring use in the scientific literature","volume":"21","author":"Pleus","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cod.13529","article-title":"Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: irritant contact dermatitis or allergic contact dermatitis?","volume":"83","author":"Herman","year":"2020","journal-title":"Contact Dermatitis"},{"key":"2026091111520584100_B93","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/1932296820918894","article-title":"Cutaneous reactions to continuous glucose monitoring and continuous subcutaneous insulin infusion devices in type 1 diabetes mellitus","volume":"15","author":"Rigo","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B94","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/1932296818762946","article-title":"Further evidence of severe allergic contact dermatitis from isobornyl acrylate while using a continuous glucose monitoring system","volume":"12","author":"Kamann","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B95","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cod.13337","article-title":"Allergic contact dermatitis caused by glucose sensors in type 1 diabetes patients","volume":"81","author":"Hyry","year":"2019","journal-title":"Contact Dermatitis"},{"key":"2026091111520584100_B96","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/1932296819870849","article-title":"Cutaneous complications with continuous or flash glucose monitoring use: systematic review of trials and observational studies","volume":"14","author":"Asarani","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B97","doi-asserted-by":"crossref","first-page":"108089","DOI":"10.1016\/j.diabres.2020.108089","article-title":"Allergic contact dermatitis in pediatric patients with type 1 diabetes: an emerging issue","volume":"162","author":"Lombardo","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091111520584100_B98","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cod.13392","article-title":"The implanted glucose monitoring system Eversense: an alternative for diabetes patients with isobornyl acrylate allergy","volume":"82","author":"Oppel","year":"2020","journal-title":"Contact Dermatitis"},{"key":"2026091111520584100_B99","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/1932296820911105","article-title":"Skin reaction report form: development and design of a standardized report form for skin reactions due to medical devices for diabetes management","volume":"15","author":"Freckmann","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/dia.2019.0159","article-title":"Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: a post-market registry study","volume":"22","author":"Deiss","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B101","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/dia.2019.0234","article-title":"Real-world data from the first U.S. commercial users of an implantable continuous glucose sensor","volume":"21","author":"Sanchez","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B102","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.2337\/dc20-3114","article-title":"Interferent effect of hydroxyurea on continuous glucose monitoring","volume":"44","author":"Szmuilowicz","year":"2021","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/19322968221095573","article-title":"Laboratory protocol and pilot results for dynamic interference testing of continuous glucose monitoring sensors","volume":"18","author":"Pf\u00fctzner","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B104","unstructured":"U.S. FDA. Summary of safety and effectiveness data (SSED). Continuous glucose monitor (CGM), implanted, adjunctive use 2018. Accessed 14 August 2025. Available from https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160048B.pdf"},{"key":"2026091111520584100_B105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13098-021-00675-y","article-title":"Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial","volume":"13","author":"Machry","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"2026091111520584100_B106","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/S0149-2918(03)80337-5","article-title":"A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial\/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus","volume":"25","author":"Korytkowski","year":"2003","journal-title":"Clin Ther"},{"key":"2026091111520584100_B107","first-page":"47","article-title":"A comparison of insulin pen devices and disposable plastic syringes - simplicity, safety, convenience and cost differences","volume":"14","author":"Singh","year":"2018","journal-title":"Eur Endocrinol"},{"key":"2026091111520584100_B108","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.mayocp.2016.06.010","article-title":"New insulin delivery recommendations","volume":"91","author":"Frid","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2026091111520584100_B109","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s12325-015-0266-5","article-title":"Characteristics relating to adherence and persistence to basal insulin regimens among elderly insulin-na\u00efve patients with type 2 diabetes: pre-filled pens versus vials\/syringes","volume":"32","author":"Slabaugh","year":"2015","journal-title":"Adv Ther"},{"key":"2026091111520584100_B110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/dia.2013.0172","article-title":"Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes","volume":"16","author":"Ahmann","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B111","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1185\/03007995.2013.825590","article-title":"Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials","volume":"29","author":"Asche","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"2026091111520584100_B112","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1399-5448.2010.00731.x","article-title":"Insulin delivery by injection in children and adolescents with diabetes","volume":"12","author":"Hanas","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"2026091111520584100_B113","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/193229681200600423","article-title":"Comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skills","volume":"6","author":"Pf\u00fctzner","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B114","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00125-024-06240-2","article-title":"Ageing well with diabetes: the role of technology","volume":"67","author":"Maltese","year":"2024","journal-title":"Diabetologia"},{"key":"2026091111520584100_B115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijnurstu.2016.04.010","article-title":"Safety of the reuse of needles for subcutaneous insulin injection: a systematic review and meta-analysis","volume":"60","author":"Zabaleta-Del-Olmo","year":"2016","journal-title":"Int J Nurs Stud"},{"key":"2026091111520584100_B116","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40271-022-00610-x","article-title":"Patients' preferences for connected insulin pens: a discrete choice experiment among patients with type 1 and type 2 diabetes","volume":"16","author":"Seo","year":"2023","journal-title":"Patient"},{"key":"2026091111520584100_B117","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2337\/dc22-0525","article-title":"Efficacy of a connected insulin pen cap in people with noncontrolled type 1 diabetes: a multicenter randomized clinical trial","volume":"46","author":"Gomez-Peralta","year":"2023","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B118","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s12325-023-02478-1","article-title":"Clinical, economic, and patient-reported benefits of connected insulin pen systems: a systematic literature review","volume":"40","author":"Cranston","year":"2023","journal-title":"Adv Ther"},{"key":"2026091111520584100_B119","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/dc23-2176","article-title":"Association between treatment adherence and continuous glucose monitoring outcomes in people with diabetes using smart insulin pens in a real-world setting","volume":"47","author":"Danne","year":"2024","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B120","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/17425247.2017.1313831","article-title":"A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice","volume":"14","author":"Bailey","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"2026091111520584100_B121","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11892-018-1097-y","article-title":"App-based insulin calculators: current and future state","volume":"18","author":"Eiland","year":"2018","journal-title":"Curr Diab Rep"},{"key":"2026091111520584100_B122","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/dia.2018.0079","article-title":"Continuous glucose monitoring and insulin informed advisory system with automated titration and dosing of insulin reduces glucose variability in type 1 diabetes mellitus","volume":"20","author":"Breton","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B123","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(19)30368-X","article-title":"Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial","volume":"393","author":"Bergenstal","year":"2019","journal-title":"Lancet"},{"key":"2026091111520584100_B124","doi-asserted-by":"crossref","first-page":"53","DOI":"10.36469\/9783","article-title":"Impact of a novel insulin management service on non-insulin pharmaceutical expenses","volume":"6","author":"Schneider","year":"2018","journal-title":"J Health Econ Outcomes Res"},{"key":"2026091111520584100_B125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12916-015-0314-7","article-title":"Smartphone apps for calculating insulin dose: a systematic assessment","volume":"13","author":"Huckvale","year":"2015","journal-title":"BMC Med"},{"key":"2026091111520584100_B126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4093\/dmj.2024.0130","article-title":"Efficacy and safety of automated insulin delivery systems in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"49","author":"Fan","year":"2025","journal-title":"Diabetes Metab J"},{"key":"2026091111520584100_B127","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s13300-023-01366-9","article-title":"Improvements in glycemic outcomes in 4738 children, adolescents, and adults with type 1 diabetes initiating a tubeless insulin management system","volume":"14","author":"Aleppo","year":"2023","journal-title":"Diabetes Ther"},{"key":"2026091111520584100_B128","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1111\/jocn.17110","article-title":"Risk predictors of glycaemic control in children and adolescents with type 1 diabetes: a systematic review and meta-analysis","volume":"33","author":"Gangqiang","year":"2024","journal-title":"J Clin Nurs"},{"key":"2026091111520584100_B129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/26350106221145323","article-title":"Racial disparities in technology use in children with type 1 diabetes: a qualitative content analysis of parents' perspectives","volume":"49","author":"Howe","year":"2023","journal-title":"Sci Diabetes Self Manag Care"},{"key":"2026091111520584100_B130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/19322968241275963","article-title":"Navigating the unique challenges of automated insulin delivery systems to facilitate effective uptake, onboarding, and continued use","volume":"19","author":"Tanenbaum","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B131","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1399-5448.2008.00416.x","article-title":"Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria","volume":"9","author":"Berghaeuser","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"2026091111520584100_B132","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2016-2534","article-title":"Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Peters","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091111520584100_B133","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S2213-8587(24)00284-5","article-title":"Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2-20 years) with type 1 diabetes: a population-based study","volume":"13","author":"Karges","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026091111520584100_B134","doi-asserted-by":"crossref","first-page":"9169296","DOI":"10.1155\/2022\/9169296","article-title":"Insulin-induced lipohypertrophy in patients with type 1 diabetes mellitus treated with an insulin pump","volume":"2022","author":"Ucieklak","year":"2022","journal-title":"Int J Endocrinol"},{"key":"2026091111520584100_B135","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1932296816663963","article-title":"Evaluation of pump discontinuation and associated factors in the T1D Exchange Clinic Registry","volume":"11","author":"Wong","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B136","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/17425247.2025.2492363","article-title":"Closed-loop therapy: recent advancements and potential predictors of glycemic outcomes","volume":"22","author":"Royston","year":"2025","journal-title":"Expert Opin Drug Deliv"},{"key":"2026091111520584100_B137","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-015-3790-6","article-title":"Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries","volume":"59","author":"Sherr","year":"2016","journal-title":"Diabetologia"},{"key":"2026091111520584100_B138","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/dia.2016.0375","article-title":"Insulin pump use in young children with type 1 diabetes: sociodemographic factors and parent-reported barriers","volume":"19","author":"Commissariat","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B139","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc18-0771","article-title":"Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial","volume":"41","author":"Forlenza","year":"2018","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B140","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1089\/dia.2018.0209","article-title":"In-clinic evaluation of the MiniMed 670G System \"suspend before low\" feature in children with type 1 diabetes","volume":"20","author":"Wood","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B141","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1089\/dia.2018.0199","article-title":"Impact of sensor-augmented pump therapy with predictive low-glucose suspend function on glycemic control and patient satisfaction in adults and children with type 1 diabetes","volume":"20","author":"Beato-V\u00edbora","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B142","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.2337\/dc20-0124","article-title":"Glycemic outcomes of use of CLC versus PLGS in type 1 diabetes: a randomized controlled trial","volume":"43","author":"Brown","year":"2020","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B143","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1089\/dia.2025.0130","article-title":"Registration and real-life studies on automated insulin delivery systems","volume":"27","author":"Akturk","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B144","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.eprac.2025.06.004","article-title":"A review of real-world evidence about the use of automated insulin delivery systems in people with type 1 diabetes","volume":"31","author":"Gera","year":"2025","journal-title":"Endocr Pract"},{"key":"2026091111520584100_B145","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.37765\/ajmc.2025.89725","article-title":"The role of advanced technologies in improving diabetes outcomes","volume":"31","author":"Marrero","year":"2025","journal-title":"Am J Manag Care"},{"key":"2026091111520584100_B146","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa2415948","article-title":"A randomized trial of automated insulin delivery in type 2 diabetes","volume":"392","author":"Kudva","year":"2025","journal-title":"N Engl J Med"},{"key":"2026091111520584100_B147","doi-asserted-by":"crossref","first-page":"e2459348","DOI":"10.1001\/jamanetworkopen.2024.59348","article-title":"Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial","volume":"8","author":"Pasquel","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026091111520584100_B148","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1007\/s00125-024-06165-w","article-title":"The role of automated insulin delivery technology in diabetes","volume":"67","author":"Boughton","year":"2024","journal-title":"Diabetologia"},{"key":"2026091111520584100_B149","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.2337\/dc13-0010","article-title":"Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes","volume":"36","author":"Sherr","year":"2013","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B150","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1111\/dom.16538","article-title":"Sustained improvements in glycaemic and psychosocial outcomes for youth and caregivers using Omnipod 5 AID for 12\u2009months","volume":"27","author":"Berget","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2026091111520584100_B151","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/1932296816640289","article-title":"Psychosocial impact of the bionic pancreas during summer camp","volume":"10","author":"Weissberg-Benchell","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B152","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2337\/dc16-1073","article-title":"Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting","volume":"39","author":"Troncone","year":"2016","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B153","doi-asserted-by":"crossref","first-page":"e000025","DOI":"10.1136\/bmjdrc-2014-000025","article-title":"Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents","volume":"2","author":"Barnard","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026091111520584100_B154","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/dia.2021.0319","article-title":"Safety and glycemic outcomes during the MiniMed advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes","volume":"24","author":"Carlson","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B155","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/dia.2023.0238","article-title":"Psychosocial impact of the insulin-only iLet bionic pancreas for adults, youth, and caregivers of youth with type 1 diabetes","volume":"25","author":"Weissberg-Benchell","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B156","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1111\/dom.16520","article-title":"Long-term health economic evaluation of automated insulin delivery system compared with continuous subcutaneous insulin infusion pumps and CGM in a real-world setting in Finnish paediatric and adult individuals with type 1 diabetes","volume":"27","author":"Vallivaara","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2026091111520584100_B157","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/dia.2023.0442","article-title":"Real-world evidence of automated insulin delivery system use","volume":"26","author":"Considine","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B158","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1089\/dia.2023.0578","article-title":"Real-world evidence of Omnipod 5 automated insulin delivery system use in 69,902 people with type 1 diabetes","volume":"26","author":"Forlenza","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B159","doi-asserted-by":"crossref","first-page":"110730","DOI":"10.1016\/j.diabres.2023.110730","article-title":"Switching from treatment with sensor augmented pump to hybrid closed loop system in type 1 diabetes: impact on glycemic control and neuropsychological tests in the real world","volume":"201","author":"Amig\u00f3","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091111520584100_B160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/dia.2022.0449","article-title":"Efficacy, safety, and satisfaction with the Accu-Chek Insight with Diabeloop closed-loop system in subjects with type 1 diabetes: a multicenter real-world study","volume":"25","author":"Chico","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B161","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/dom.15008","article-title":"One-year real-world performance of the DBLG1 closed-loop system: data from 3706 adult users with type 1 diabetes in Germany","volume":"25","author":"Benhamou","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"2026091111520584100_B162","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1177\/19322968231186976","article-title":"First generation of a modular interoperable closed-loop system for automated insulin delivery in patients with type 1 diabetes: lessons from trials and real-life data","volume":"17","author":"Benhamou","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B163","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/dia.2022.0558","article-title":"A meta-analysis of randomized trial outcomes for the t:slim X2 insulin pump with Control-IQ technology in youth and adults from age 2 to 72","volume":"25","author":"Beck","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B164","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/dom.15023","article-title":"Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system","volume":"25","author":"Grassi","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"2026091111520584100_B165","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1089\/dia.2022.0206","article-title":"Real-world evidence supporting tandem Control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations","volume":"24","author":"Forlenza","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B166","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40801-019-00173-8","article-title":"Effectiveness of V-Go for patients with type 2 diabetes in a real-world setting: a prospective observational study","volume":"7","author":"Grunberger","year":"2020","journal-title":"Drugs Real World Outcomes"},{"key":"2026091111520584100_B167","first-page":"1111","article-title":"Effect of V-Go versus multiple daily injections on glycemic control, insulin use, and diabetes medication costs among individuals with type 2 diabetes mellitus","volume":"25","author":"Raval","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"2026091111520584100_B168","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/1932296815580361","article-title":"V-Go insulin delivery system versus multiple daily insulin injections for patients with uncontrolled type 2 diabetes mellitus","volume":"9","author":"Winter","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B169","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/dia.2018.0298","article-title":"Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen","volume":"21","author":"Bergenstal","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S2213-8587(21)00267-9","article-title":"Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals","volume":"10","author":"Braune","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026091111520584100_B171","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/dia.2020.0535","article-title":"A real-world prospective study of the safety and effectiveness of the loop open source automated insulin delivery system","volume":"23","author":"Lum","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B172","doi-asserted-by":"crossref","first-page":"e25409","DOI":"10.2196\/25409","article-title":"Why #WeAreNotWaiting-motivations and self-reported outcomes among users of open-source automated insulin delivery systems: multinational survey","volume":"23","author":"Braune","year":"2021","journal-title":"J Med Internet Res"},{"key":"2026091111520584100_B173","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMoa2203913","article-title":"Open-source automated insulin delivery in type 1 diabetes","volume":"387","author":"Burnside","year":"2022","journal-title":"N Engl J Med"},{"key":"2026091111520584100_B174","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/dia.2022.0562","article-title":"First use of open-source automated insulin delivery AndroidAPS in full closed-loop scenario: Pancreas4ALL randomized pilot study","volume":"25","author":"Petruzelkova","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B175","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/19322968231164166","article-title":"The first regulatory clearance of an open-source automated insulin delivery algorithm","volume":"17","author":"Braune","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B176","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/dia.2020.0375","article-title":"The digital\/virtual diabetes clinic: the future is now-recommendations from an international panel on diabetes digital technologies introduction","volume":"23","author":"Phillip","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B177","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/dci19-0062","article-title":"Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group","volume":"43","author":"Fleming","year":"2020","journal-title":"Diabetes Care"},{"key":"2026091111520584100_B178","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1089\/dia.2018.0251","article-title":"A pilot study of use of a software platform for the collection, integration, and visualization of diabetes device data by health care providers in a multidisciplinary pediatric setting","volume":"20","author":"Wong","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B179","doi-asserted-by":"crossref","first-page":"e11017","DOI":"10.2196\/11017","article-title":"Enhanced self-efficacy and behavioral changes among patients with diabetes: cloud-based mobile health platform and mobile app service","volume":"4","author":"Chao","year":"2019","journal-title":"JMIR Diabetes"},{"key":"2026091111520584100_B180","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0145721714531339","article-title":"Translating the diabetes prevention program into an online social network: validation against CDC standards","volume":"40","author":"Sepah","year":"2014","journal-title":"Diabetes Educ"},{"key":"2026091111520584100_B181","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1089\/dia.2019.2506","article-title":"Using digital health technology to prevent and treat diabetes","volume":"21","author":"Kaufman","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B182","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.2196\/diabetes.9059","article-title":"Perceptions of persons with type 2 diabetes treated in Swedish primary health care: qualitative study on using eHealth services for self-management support","volume":"3","author":"\u00d6berg","year":"2018","journal-title":"JMIR Diabetes"},{"key":"2026091111520584100_B183","doi-asserted-by":"crossref","first-page":"3961730","DOI":"10.1155\/2018\/3961730","article-title":"Remote lifestyle coaching plus a connected glucose meter with certified diabetes educator support improves glucose and weight loss for people with type 2 diabetes","volume":"2018","author":"Bollyky","year":"2018","journal-title":"J Diabetes Res"},{"key":"2026091111520584100_B184","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.2196\/resprot.4838","article-title":"Evidence-based mHealth chronic disease mobile app intervention design: development of a framework","volume":"5","author":"Wilhide Iii","year":"2016","journal-title":"JMIR Res Protoc"},{"key":"2026091111520584100_B185","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1177\/1932296819888662","article-title":"A virtual type 2 diabetes clinic using continuous glucose monitoring and endocrinology visits","volume":"14","author":"Dixon","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111520584100_B186","doi-asserted-by":"crossref","first-page":"e16266","DOI":"10.2196\/16266","article-title":"Effect of a mobile phone-based glucose-monitoring and feedback system for type 2 diabetes management in multiple primary care clinic settings: cluster randomized controlled trial","volume":"8","author":"Yang","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"2026091111520584100_B187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2019.0273","article-title":"Reviewing U.S. connected diabetes care: the newest member of the team","volume":"22","author":"Levine","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2026091111520584100_B188","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/dme.13929","article-title":"Text-message responsiveness to blood glucose monitoring reminders is associated with HbA1c benefit in teenagers with type 1 diabetes","volume":"36","author":"McGill","year":"2019","journal-title":"Diabet Med"},{"key":"2026091111520584100_B189","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.2196\/jmir.9133","article-title":"Effectiveness of internet-based interventions on glycemic control in patients with type 2 diabetes: meta-analysis of randomized controlled trials","volume":"20","author":"Shen","year":"2018","journal-title":"J Med Internet Res"},{"key":"2026091111520584100_B190","doi-asserted-by":"crossref","first-page":"e47638","DOI":"10.2196\/47638","article-title":"Impact of a combined continuous glucose monitoring-digital health solution on glucose metrics and self-management behavior for adults with type 2 diabetes: real-world, observational study","volume":"8","author":"Kumbara","year":"2023","journal-title":"JMIR Diabetes"},{"key":"2026091111520584100_B191","unstructured":"U.S. Food and Drug Administration\n          . Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use. Guidance for Industry and Food and Drug Administration Staff, September 2020. Accessed 19 August 2025. Available from https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/self-monitoring-blood-glucose-test-systems-over-counter-use"},{"key":"2026091111520584100_B192","author":"U.S. Food and Drug Administration","year":"2020"},{"key":"2026091111520584100_B193","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/1932296816644468","article-title":"The quantitative relationship between ISO 15197 accuracy criteria and mean absolute relative difference (MARD) in the evaluation of analytical performance of self-monitoring of blood glucose (SMBG) systems","volume":"10","author":"Pardo","year":"2016","journal-title":"J Diabetes Sci Technol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/Supplement_1\/S150\/848844\/dc26s007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/Supplement_1\/S150\/848844\/dc26s007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:53:14Z","timestamp":1789141994000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/Supplement_1\/S150\/163922\/7-Diabetes-Technology-Standards-of-Care-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":193,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2025,12,8]]},"published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-s007","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}